- Home
- GFF vs ALVO Comparison
GFF vs ALVO Comparison
Compare GFF & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFF
- ALVO
- Stock Information
- Founded
- GFF 1959
- ALVO 2013
- Country
- GFF United States
- ALVO Luxembourg
- Employees
- GFF N/A
- ALVO N/A
- Industry
- GFF Building Products
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- GFF Industrials
- ALVO Health Care
- Exchange
- GFF Nasdaq
- ALVO Nasdaq
- Market Cap
- GFF 3.8B
- ALVO 3.4B
- IPO Year
- GFF N/A
- ALVO N/A
- Fundamental
- Price
- GFF $72.76
- ALVO $11.91
- Analyst Decision
- GFF Strong Buy
- ALVO Buy
- Analyst Count
- GFF 4
- ALVO 1
- Target Price
- GFF $89.25
- ALVO $18.00
- AVG Volume (30 Days)
- GFF 393.2K
- ALVO 143.5K
- Earning Date
- GFF 02-05-2025
- ALVO 11-13-2024
- Dividend Yield
- GFF 0.99%
- ALVO N/A
- EPS Growth
- GFF 197.89
- ALVO N/A
- EPS
- GFF 4.23
- ALVO N/A
- Revenue
- GFF $2,623,520,000.00
- ALVO $393,919,000.00
- Revenue This Year
- GFF $0.93
- ALVO $398.12
- Revenue Next Year
- GFF $3.10
- ALVO $44.73
- P/E Ratio
- GFF $17.22
- ALVO N/A
- Revenue Growth
- GFF N/A
- ALVO 517.92
- 52 Week Low
- GFF $55.01
- ALVO $9.15
- 52 Week High
- GFF $86.73
- ALVO $18.00
- Technical
- Relative Strength Index (RSI)
- GFF 38.14
- ALVO 49.73
- Support Level
- GFF $71.01
- ALVO $11.20
- Resistance Level
- GFF $82.32
- ALVO $12.25
- Average True Range (ATR)
- GFF 2.21
- ALVO 0.29
- MACD
- GFF -1.56
- ALVO 0.08
- Stochastic Oscillator
- GFF 14.47
- ALVO 67.62
About GFF Griffon Corporation
Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products and Home and Building Products. The company generates a majority of its revenue from the Home and Building Products segment.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.